GlassScriptPhysician profile
Elisa Arnold
NPI 1215618053
$3,000.16
in general payments reported to CMS, 2019-2025
11 companies · $2,905 in 2025
The $2,905 reported for 2025 was more than what 96% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $95.24 · 2025: $2,905.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,955 · Food and Beverage: $1,045.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,955.38 |
| Food and Beverage | $1,044.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,758.63 | 2025 | Evarrest |
| Getinge USA Sales, LLC | $489.23 | 2025 | Vasoview Hemopro 2 |
| Bridgebio Pharma, INC. | $186.07 | 2025 | Attruby |
| Abiomed | $184.20 | 2025 | |
| Amarin Pharma, INC. | $124.99 | 2025 | Vascepa |
| Ethicon US, LLC | $116.33 | 2025 | Evarrest, Vistaseal, Prolene |
| Davol INC. | $45.47 | 2025 | Progel Applicator Spray Tips |
| Bolton Medical INC | $29.52 | 2024 | Treo Abdominal Stent-Graft System |
| Merck Sharp & Dohme LLC | $24.86 | 2024 | Keytruda, Lynparza |
| Aveo Pharmaceuticals, INC. | $20.77 | 2024 | |
| Sobi, INC | $20.09 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elisa Arnold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.